 - Other laboratory abnormalities or concurrent diseasesclinical: clinically significant laboratory abnormality, uncontrolled condition or disease state that, in the opinion of the investigator in consultation with the GSK Medical Monitor, if required, would put the safety of the subject at risk through study participation or would confound the interpretation of the efficacy results if the conditiondisease exacerbated during the study. 